Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 27, 2000
Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based studyA Chao, F Gilliland, C Willman, et al.
European Journal of Haematology|November 6, 2023
Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of MichiganCharles E Foucar, Daniel H Foley, Jessica Aldous, et al.
The American Journal of Pathology|March 1, 1995
Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious diseaseS R Zaki, P W Greer, L M Coffield, et al.
Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.
Ejhaem|August 19, 2024
Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemiaAlexandra E Rojek, Benjamin J McCormick, Joanna Cwykiel, et al.
American Journal of Clinical Pathology|January 25, 2018
T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology GroupTanu Goyal, Beenu Thakral, Sa A Wang, et al.
Cancer|November 14, 2025
Chronic myelomonocytic leukemia in the young (aged 50 years and younger): Divergent clinical and molecular characteristics from the elderlyChi Young Ok, Anuya Natu, Parnaz Daneshpajouhnejad, et al.
Leukemia & Lymphoma|April 9, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Razan Mohty, Ravi Narra, Alice S Mims, et al.
British Journal of Haematology|December 3, 2025
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortiumDaniel T Peters, Deedra Nicolet, Yazan F Madanat, et al.
Blood Advances|January 15, 2026
Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review & meta-analysisMaria Jose Oliveros, Saifur R Chowdhury, Yetiani Roldan, et al.
Pageof 12